Discontinued weight loss drugs

symptoms generally improve after reduction in dose or discontinuation of drug Anorexia (loss of appetite). 2.9. Insomnia. 1.5. Weight Loss.

Wellbutrin and weight loss. Weight loss is a common side effect of Upon discontinuing Wellbutrin, a healthcare provider may

Table 3: Chronic WMM Comparison of Weight Loss and Discontinuation Due to Adverse Events Medication for Weight Loss % Weight Loss vs Baseline 5% Weight Loss (OR) 10% Weight Loss (OR) Discontinuation Due to Adverse Events (OR) Orlistat 14 -3.2% 2.73 2.43 1.72 Naltrexone/bupropion14-4.1% 5.04 5.19 2.69

Ranitidine, a drug used for ulcers and gastroesophageal reflux disease (discontinued in 2024); Phentermine, a weight loss drug; Phenylephrine

Ranitidine, a drug used for ulcers and gastroesophageal reflux disease (discontinued in 2024); Phentermine, a weight loss drug; Phenylephrine

odds ratio (OR) of patients able to achieve a 5% or greater weight loss, or discontinuation due to an adverse event in clinical trials compared to lifestyle modification. Table 3: Chronic WMM Comparison of Weight Loss and Discontinuation Due to Adverse Events Medication for Weight Loss % Weight Loss vs Baseline 5% Weight Loss (OR)

In one of these studies, it was after weight loss had been maintained for 3 years – when the drug was discontinued, the weight returned rapidly

Ranitidine, a drug used for ulcers and gastroesophageal reflux disease (discontinued in 2024); Phentermine, a weight loss drug; Phenylephrine

The Didrex brand name has been discontinued in the U.S. Find out everything you need to know about weight loss drugs in our prescription weight loss drug guide.